Screener
Acadia Pharmaceuticals ACAD Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's price / book?
- Acadia Pharmaceuticals (ACAD) reported price / book of 3.3× in Q2 2026.
- How has Acadia Pharmaceuticals's price / book changed year-over-year?
- Acadia Pharmaceuticals's price / book decreased by 27.3% year-over-year, from 4.6× to 3.3×.
- What is the long-term trend for Acadia Pharmaceuticals's price / book?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's price / book has grown at a -23.1% compound annual growth rate (CAGR), from 13.7× to 3.7×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Acadia Pharmaceuticals's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude